Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc.（APGE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
apge · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$140
Consensus
$111
+30.9% upside
Low
$81.00
Median: $103 · Last Close: $84.77
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$111.00
30.9% upside
High Target
$140
65.2%
Low Target
$81
-4.4%
Current Price
$84.77
as of today
Based on analyst price targets, the APGE stock price prediction for the next 12 months ranges from $81 to $140. The consensus APGE price forecast of $111.00 implies 30.9% upside from the current price of $84.77.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $87.46 | ↑ 3.18% |
1-day model range: $86.93–$87.99. Peak: $87.99 (+3.18%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $150 | +76.4% |
| 2028 | $218 | +157.3% |
| 2029 | $278 | +228.0% |
| 2030 | $324 | +282.2% |
| 2031 | — | +320.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · APGE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-27 | Truist Securities | Maintains | Hold→Hold |
| 2026-05-27 | BTIG | Maintains | Buy→Buy |
| 2026-05-27 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-30 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-03-24 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-24 | Citigroup | Maintains | Buy→Buy |
| 2026-03-23 | BTIG | Maintains | Buy→Buy |
| 2026-03-16 | BTIG | Maintains | Buy→Buy |
| 2026-03-03 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Apogee Therapeutics, Inc. (APGE) stock. Of the recent 28 rating actions, 0 were upgrades and 1 were downgrades. 11 analysts currently cover APGE.
分析师推荐趋势
APGE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$14M
↓ 79.6% YoY
Revenue Next Year
$13M
↓ 12.5% YoY
EPS This Year
$-4.40
EPS Next Year
$-5.35
↑ 21.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast APGE EPS of $-4.40 for the current fiscal year, based on estimates from 11 analysts. The APGE revenue forecast is $14M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
APGE 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。APGE 的共识目标价为 $111.00（+30.9% 上行空间），分析师共识为 Buy。
APGE 的短期预测（明日）为 $87.46（+3.18%）。 APGE 对 2027 年的股价预测均值为 $150。 APGE 对 2030 年的预测区间为 $302–$346。
Apogee Therapeutics, Inc. 在 NASDAQ 上市，代码 APGE。APGE 在 2027 年的整体展望偏积极，在覆盖分析师中约 82% 对应 Buy 共识。
常见问题
APGE 预测 · 8 个问题根据 11 位华尔街分析师，APGE 的 12 个月平均目标价为 $111.00，最高 $140.00、最低 $81.00。若有图表，中位目标价可在上方查看。相对当前价 $84.77，隐含约 +30.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.